introducing novel immunotherapeutic approaches for metastatic nsclc without driver mutations
Published 1 year ago • 90 plays • Length 47:52Download video MP4
Download video MP3
Similar videos
-
33:28
novel targeted therapies for nsclc: exploring her2 dysregulation
-
18:01
overcoming challenges in advanced or metastatic squamous cell lung cancer: focus on immunotherapy
-
0:58
novel immunotherapeutic strategies in lung cancer
-
32:14
navigating the complexities of the nsclc treatment pathway: a focus on antibody-drug conjugates
-
1:24
novel immunotherapies for colorectal cancer
-
57:45
dna graffiti: mutation patterns in cancer | the royal society
-
1:03:22
breakthrough cancer treatment: alpha radiation therapy by dr. robert den | tcp ep.67
-
1:27:54
2024 kias: tumor heterogeneity and drug resistance session 1, part1
-
2:26
novel tracer developed for precision targeting of non-small cell lung cancer
-
22:06
the basics of immunotherapy in non-small cell lung cancer (nsclc)
-
1:28
the role of immunotherapy in sclc
-
2:20
novel immunotherapy combinations for nsclc
-
37:25
personalized therapy for nsclc: biomarker testing, treatment and management in met alterations
-
7:00
novel immunotherapy combinations in nsclc
-
0:36
how immunotherapy works for lung cancer
-
3:48
i-o as first-line therapy for driver-mutated nsclc
-
1:04:50
a new era has begun in the treatment of sclc: navigating novel therapeutic options and strategies
-
20:05
what is the role of immunotherapy for patients with advanced nsclc and a driver mutation?
-
0:50
research into new immunotherapies for breast cancer
-
1:53
the introduction of novel immunotherapies and the pharmacist
-
2:53
essential small cell lung cancer testing
-
3:23
episode 1: introduction to this podcast series